About Neuroprex
Neuroprex is a Healthcare company based in Santa Clara (United States) founded in 2012 by Janice Huang. Wearable devices are developed to modulate tissues for neurological diseases. Neuroprex has raised $50 thousand across 4 funding rounds from investors including European Union, National Science Foundation and EIC Fund. Its chief executive, as recorded, is Janice Huang. Neuroprex offers products and services including NPX. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is NeuroPrex Inc. Its competitors include NeuroStar, Soterix Medical and TMSWorkbook; 1 of its 3 listed competitors has raised funding.
Company details
Neuroprex was founded in 2012 and is located in Santa Clara, United States. Wearable devices are developed by the company within the medical technology sector to address neurological conditions. A Transcranial Magnetic Stimulation (TMS) device is provided, featuring star-shaped electromagnetic coils integrated into a surface pain reduction shield layer. Nerve activities in brain and body tissues linked to depression, PTSD, and related disorders are targeted for modulation through these operations.
- Headquarters Santa Clara, United States
- Founders Janice Huang
- SectorsHealthcare
- Email••••••••
- Website neuroprexinc.com
- Legal Name Neuroprex Inc
- Total Equity Funding$50K (USD)
in 4 rounds
- Latest Funding Round$224.93K (USD), Grant
Jul 2018
- InvestorsEuropean Union
& 2 more
Products & Services of Neuroprex
Neuroprex offers a comprehensive portfolio of products and services, including NPX.
Wearable for treating drug-resistant depression and PTSD via magnetic stimulation.
Funding Insights of Neuroprex
Neuroprex has successfully raised a total of $50K across 4 strategic funding rounds. The most recent funding activity was a Grant round of $224.93 thousand completed in July 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $50,000
- Total Rounds 4
- Last Round Grant — $224,925
- First Round $50,000
(Jan 2013)
- Investors Count 3
All 4 funding rounds of Neuroprex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2018 | $224,925 | Grant | – | – | |
| Sep 2016 | $56,109 | Grant | – | – | |
| Jun 2016 | $55,934 | Grant | – | – | |
| Jan 2013 | $50,000 | Seed | – | – | – |
3 investors in total: 3 institutional.
Investors in Neuroprex
Neuroprex has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, National Science Foundation and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Neuroprex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Neuroprex
5 people are tracked at Neuroprex (1 in leadership, 4 in board & advisors).
| Name | Role | Group |
|---|---|---|
Janice Huang | Founder & CEO | Leadership |
David Gudeman | Advisor | Board & advisors |
Bill PC Hsieh | Advisor | Board & advisors |
Fred M. Greguras | Advisor | Board & advisors |
Pablo Villoslada | Advisor | Board & advisors |
Complete people profiles for Neuroprex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Neuroprex
3 dated milestones of Neuroprex across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Neuroprex is founded.
- Funding First funding round of $50K.
- Funding Latest funding round, Grant, of $225K.
Competitors of Neuroprex
Neuroprex has 3 listed competitors in our database, 1 of them funded. They include NeuroStar, Soterix Medical and TMSWorkbook.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| neurostar.com | 2003 | Malvern, United States | $118.69M | 151 | Non-invasive TMS therapy is provided for major depressive disorder treatment. | |
| soterixmedical.com | 2008 | New York, United States | Non-invasive neuromodulation devices for mood disorders are manufactured. | |||
| tmsworkbook.com | 2018 | Nashville, United States | Digital platform for TMS therapy modules and patient assessments. |
Detailed competitors of Neuroprex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Neuroprex
Websites that share an audience with Neuroprex (neuroprexinc.com).
Websites whose visitors overlap most with Neuroprex. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
neuromodec.org | neuromodec.org | 100% | #1,334,292 | – |
Top companies in Neurology
3 companies that operate in the same segment as Neuroprex (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Neuroprex
Neuroprex was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Neuroprex is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
Janice Huang is the CEO of Neuroprex, as recorded in our data. They have also founded this company.
Neuroprex is a funded company, having raised a total of $50K across 4 funding rounds to date. The company's 1st funding round was a Seed of $50K, raised on Jan 2013.
Neuroprex was founded in 2012 and is located in Santa Clara, United States. Wearable devices are developed by the company within the medical technology sector to address neurological conditions. A Transcranial Magnetic Stimulation (TMS) device is provided, featuring star-shaped electromagnetic coils integrated into a surface pain reduction shield layer. Nerve activities in brain and body tissues linked to depression, PTSD, and related disorders are targeted for modulation through these operations.
Neuroprex's top competitors include NeuroStar, Soterix Medical and TMSWorkbook.
Neuroprex offers NPX.
Neuroprex has 3 investors. Key investors include European Union, National Science Foundation, and EIC Fund.
Neuroprex operates through Neuroprex Inc.